Peter S. Choi

6.2k total citations · 1 hit paper
45 papers, 4.3k citations indexed

About

Peter S. Choi is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter S. Choi has authored 45 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter S. Choi's work include RNA modifications and cancer (8 papers), RNA Research and Splicing (7 papers) and Ubiquitin and proteasome pathways (5 papers). Peter S. Choi is often cited by papers focused on RNA modifications and cancer (8 papers), RNA Research and Splicing (7 papers) and Ubiquitin and proteasome pathways (5 papers). Peter S. Choi collaborates with scholars based in United States, Canada and China. Peter S. Choi's co-authors include Matthew Meyerson, Benjamin Wolozin, Leonard Petrucelli, John Hardy, Matthew J. Farrer, Katalin Suszták, Yi-An Ko, Ae Seo Deok Park, Hyun Mi Kang and Jianling Tao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Peter S. Choi

40 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development

2014 1.1k citations Peter S. Choi, Yi-An Ko et al. profile →

Peers

Countries citing papers authored by Peter S. Choi

Since Specialization

Citations

This map shows the geographic impact of Peter S. Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter S. Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter S. Choi more than expected).

Fields of papers citing papers by Peter S. Choi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter S. Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter S. Choi. The network helps show where Peter S. Choi may publish in the future.

Co-authorship network of co-authors of Peter S. Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Peter S. Choi. A scholar is included among the top collaborators of Peter S. Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter S. Choi. Peter S. Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A deep dive into statistical modeling of RNA splicing QTLs reveals variants that explain neurodegenerative disease 2025 ·The American Journal of Human Genetics ·David Wang, Matthew R. Gazzara, (unknown), (unknown), (unknown), Christopher D. Brown, Peter S. Choi, Yoseph Barash	0
2	Machine learning-optimized targeted detection of alternative splicing 2024 ·Nucleic Acids Research ·(unknown), (unknown), (unknown), Di Wu, Anupama Jha, Caleb M. Radens, Jeffrey A. Pleiss, Kristen W. Lynch, Yoseph Barash, Peter S. Choi	0
3	A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancer 2021 ·Nature Communications ·Yanli Liu, Zhong Wu, Jin Zhou, (unknown), (unknown), (unknown), Yifei Yan, Xiaojun Yang, Alison M. Taylor, Katherine E. Varley, Jason Gertz, Peter S. Choi, Andrew D. Cherniack, Xingdong Chen, Adam J. Bass, Swneke D. Bailey, Xiaoyang Zhang	24
4	Chromatin Looping Shapes KLF5-Dependent Transcriptional Programs in Human Epithelial Cancers 2020 ·Cancer Research ·Yanli Liu, Bingqian Guo, (unknown), (unknown), Jin Zhou, Zhong Wu, Joshua M. Francis, Xiaojun Yang, Peter S. Choi, Swneke D. Bailey, Xiaoyang Zhang	32
5	Identification and Characterization of Oncogenic SOS1 Mutations in Lung Adenocarcinoma 2019 ·Molecular Cancer Research ·Diana Cai, Peter S. Choi, (unknown), Matthew Meyerson	30
6	Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 2018 ·Nature Communications ·Hugh Gannon, Tao Zou, Michael K. Kießling, Galen F. Gao, Diana Cai, Peter S. Choi, (unknown), Ilana Buchumenski, Ashton C. Berger, Jonathan T. Goldstein, Andrew D. Cherniack, Francisca Vázquez, Aviad Tsherniak, Erez Y. Levanon, William C. Hahn, Matthew Meyerson	159
7	Somatic Superenhancer Duplications and Hotspot Mutations Lead to Oncogenic Activation of the KLF5 Transcription Factor 2017 ·Cancer Discovery ·Xiaoyang Zhang, Peter S. Choi, Joshua M. Francis, Galen F. Gao, Joshua D. Campbell, Aruna Ramachandran, Yoichiro Mitsuishi, Gavin Ha, Juliann Shih, Francisca Vázquez, Aviad Tsherniak, Alison M. Taylor, Jin Zhou, Zhong Wu, Ashton C. Berger, Marios Giannakis, William C. Hahn, Andrew D. Cherniack, Matthew Meyerson	85
8	MET Exon 14 Mutation Encodes an Actionable Therapeutic Target in Lung Adenocarcinoma 2017 ·Cancer Research ·Xinyuan Lu, Nir Peled, John J. Greer, Wei Wu, Peter S. Choi, Alice H. Berger, Sergio Wong, Kuang‐Yu Jen, Youngho Seo, Byron Hann, Angela N. Brooks, Matthew Meyerson, Eric A. Collisson	49
9	Identification and Characterization of Oncogenic SOS1 Mutations in Lung Adenocarcinoma 2017 ·Journal of Thoracic Oncology ·Daoping Cai, Peter S. Choi, Matthew Meyerson	3
10	Human Kidney Tubule-Specific Gene Expression Based Dissection of Chronic Kidney Disease Traits 2017 ·EBioMedicine ·Pazit Beckerman, Chengxiang Qiu, Jihwan Park, Nóra Ledó, Yi-An Ko, (unknown), Sang Youb Han, Peter S. Choi, Matthew Palmer, Katalin Suszták	54
11	Functional Genomic Annotation of Genetic Risk Loci Highlights Inflammation and Epithelial Biology Networks in CKD 2014 ·Journal of the American Society of Nephrology ·Nóra Ledó, Yi-An Ko, (unknown), Hyun Mi Kang, Sang Youb Han, Peter S. Choi, Katalin Suszták	43
12	Targeted genomic rearrangements using CRISPR/Cas technology 2014 ·Nature Communications ·Peter S. Choi, Matthew Meyerson	229
13	Activation of Cre Recombinase Alone Can Induce Complete Tumor Regression 2014 ·PLoS ONE ·Yulin Li, Peter S. Choi, Stephanie C. Casey, Dean W. Felsher	17
14	The interaction between Myc and Miz1 is required to antagonize TGFβ-dependent autocrine signaling during lymphoma formation and maintenance 2010 ·Genes & Development ·Jan van Riggelen, Judith M. Müller, Tobias Otto, Vincent Beuger, Alper Yetil, Peter S. Choi, Christian Kosan, Tarik Möröy, Dean W. Felsher, Martin Eilers	94
15	A family of Gram-negative bacterial outer membrane factors that function in the export of proteins, carbohydrates, drugs and heavy metals from Gram-negative bacteria 2006 ·FEMS Microbiology Letters ·Ian T. Paulsen, Jay Park, Peter S. Choi, Milton H. Saier	135
16	P2Y-like receptor, GPR105 (P2Y₁₄), identifies and mediates chemotaxis of bone-marrowhematopoietic stem cells 2003 ·Genes & Development ·Byeong-Chel Lee, Tao Cheng, Gregor B. Adams, Eyal C. Attar, Nobuyuki Miura, Sean Bong Lee, Yoriko Saito, Ivona T. Olszak, David Dombkowski, Douglas P. Olson, (unknown), Peter S. Choi, Daniel A. Haber, Andrew D. Luster, David T. Scadden	81
17	SEPT5_v2 is a parkin-binding protein 2003 ·Molecular Brain Research ·Peter S. Choi, Heather M. Snyder, Leonard Petrucelli, Catherine Theisler, Matthew Chong, Yuesheng Zhang, Kah‐Leong Lim, Kenny K. K. Chung, Kathryn Kehoe, Luciano D’Adamio, (unknown), (unknown), (unknown), Ted M. Dawson, Benjamin Wolozin	94
18	Parkin Protects against the Toxicity Associated with Mutant α-Synuclein 2002 ·Neuron ·Leonard Petrucelli, Casey O’Farrell, Paul J. Lockhart, Melisa J. Baptista, Kathryn Kehoe, (unknown), Peter S. Choi, Benjamin Wolozin, Matthew J. Farrer, John Hardy, Mark Cookson	457
19	Co-association of parkin and α-synuclein 2001 ·Neuroreport ·Peter S. Choi, (unknown), Heather M. Snyder, Matthew Chong, Leonard Petrucelli, John Hardy, Dennis R. Sparkman, Elizabeth J. Cochran, (unknown), Benjamin Wolozin	63
20	Hodgkin's disease in Hong Kong Chinese 1989 ·Hematological Oncology ·Raymond Liang, Peter S. Choi, (unknown), T. K. Chan, Damon Choy, Faith Ho	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact